Confirmatory Discovery definition

Confirmatory Discovery means the factual information that Defendant will provide to Lead Plaintiff subject to Section II below.
Confirmatory Discovery means that discovery concluded by Settlement Class Counsel to perform their due diligence with respect to the fairness and appropriateness of the terms of the Amended Settlement Agreement and this Second Amended Settlement Agreement to the Putative Class Members and the Settlement Class Members in relation to the factual basis for the lawsuit; 1.11 “Court” means the United States District Court for the Southern District of Florida, Miami Division.
Confirmatory Discovery means the documents and other factual information that Schein has provided or shall provide Derivative Plaintiffs (through Derivative Co-Lead Counsel) access during the Confirmatory Discovery Period.

Examples of Confirmatory Discovery in a sentence

  • Lead Plaintiffs and Lead Counsel also are mindful of the inherent problems of proof under and possible defenses to the securities law violations asserted in the Action, and they have reviewed the Confirmatory Discovery.

  • Plaintiff may terminate this Settlement based upon a good faith determination that confirmatory discovery has not corroborated material facts and information provided during informal discovery and settlement discussions, but this right of termination is void and of no further force and effect if notice of termination is not provided within 5 business days of the close of the Confirmatory Discovery Deadline.

  • Confirmatory Discovery: Defendants have also agreed to provide documents and information to Class Counsel showing that Defendants have taken data security measures to remedy the issues that led to the Data Incidents and has implemented other business practices to help ensure information security.

  • The Settling Parties may agree in writing, through counsel, to extend the Confirmatory Discovery Deadline.

  • This Settlement is subject to reasonable confirmatory discovery to take place prior to November 26, 2012 (hereinafter referred to as "Confirmatory Discovery Deadline") for purposes of corroborating the material information provided to Class Counsel during settlement discussions.

  • Confirmatory Discovery: Defendant has also agreed to provide documents and information to Class Counsel showing that MMC has taken data security measures to remedy the issues that led to the Data Security Incident and has implemented other business practices to help ensure information security.

  • If the settlement contemplated by this Settlement Agreement is terminated or does not obtain Final Approval, then all discovery materials or information obtained in connection with Confirmatory Discovery shall be rendered null and void, shall be deemed not taken, and shall not be used in All Cases.

  • Each Class Member will be assigned an Overtime Pay Factor which will be the product of such Class Member’s actual overtime hours worked (as reflected in Swift’s employment records and subject to Confirmatory Discovery) multiplied by such Class Member’s per mile pay rate at the time such overtime hours were worked (as reflected in Swift’s employment records and subject to Confirmatory Discovery).


More Definitions of Confirmatory Discovery

Confirmatory Discovery means discovery of third parties relating solely to this settlement and necessary to demonstrate the appropriateness, adequacy and/or practicability of the program(s) to be established pursuant to Section IV of this Settlement Agreement. It shall not include, among other things, discovery on the merits with respect to All Claims.
Confirmatory Discovery means that discovery concluded by Settlement Class Counsel to perform their due diligence with respect to the fairness and appropriateness of the terms of the Amended Settlement Agreement, the Second Amended Settlement Agreement and this Third Amended Settlement Agreement to the Putative Class Members and the Settlement Class Members in relation to the factual basis for the lawsuit; 1.11 “Court” means the United States District Court for the Southern District of Florida, Miami Division.
Confirmatory Discovery means the discovery conducted by Co-Lead Counsel relating to the allegations in the Action that was necessary for Co-Lead Counsel to confirm the reasonableness of the Settlement.
Confirmatory Discovery means such reasonable and additional discovery being taken and to be taken subsequent to this Stipulation as is appropriate and necessary and as agreed to by counsel for the parties to confirm the fairness and reasonableness of the terms of this settlement.
Confirmatory Discovery means any and all documents, transcripts, or other information provided by any Defendant to Plaintiffs' Co-Lead Counsel pursuant to the terms of the parties' Memorandum of Understanding dated as of May 16, 2002.

Related to Confirmatory Discovery

  • Step therapy protocol means a protocol or program that establishes the specific

  • Field means [***].

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Research record means any data, document, computer file, computer diskette, or any other written or non-written account or object that reasonably may be expected to provide evidence or information regarding the proposed, conducted, or reported research that constitutes the subject of an allegation of research misconduct. A research record includes, but is not limited to, grant or contract applications, whether funded or unfunded; grant or contract progress and other reports; laboratory notebooks; notes; correspondence; videos; photographs; X-ray film; slides; biological materials; computer files and printouts; manuscripts and publications; equipment use logs; laboratory procurement records; animal facility records; human and animal subject protocols; consent forms; medical charts; and patient research files.

  • Regulatory Approval Application means an application to seek regular or expedited Regulatory Approval of the Licensed Product for sale or marketing in any country(ies) or Region(s) in the Territory, as defined in the applicable Laws and filed with the Regulatory Authority of such country(ies) or Region(s).

  • Indication means any disease or condition, or sign or symptom of a disease or condition.

  • Research Results means any technical result acquired based on the Collaborative Research, including, but not limited to, any invention, idea, design, copyrightable work and know-how which relates to the purpose of the Collaborative Research.

  • Discovery means the finding, during Petroleum Operations, of a deposit of Petroleum not previously known to have existed, which can be recovered at the surface in a flow measurable by conventional petroleum industry testing methods.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Responsive Proposal means a Proposal that complies with the material provisions of this RFP.

  • Practical application means to manufacture in the case of a composition or product, to practice in the case of a process or method, or to operate in the case of a machine or system; and, in each case, under such conditions as to establish that the invention is being utilized and that its benefits are, to the extent permitted by law or government regulations, available to the public on reasonable terms.

  • First Indication means the first disease condition for which a particular Licensed Product has been approved by a Regulatory Authority.

  • FDA Approval means with respect to the Product, a Regulatory Approval by the FDA for the commercial use of the Product in the United States.

  • Step therapy means a protocol or

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Commercial Discovery means a Discovery of Petroleum reserves which has been declared as a Commercial Discovery in accordance with the provisions of Article 10 and/or Article 21.

  • NDA Approval means the Approval of an NDA by the FDA for a Product in the U.S.

  • Regulatory Approval means, with respect to a Product in any country or jurisdiction, any approval (including where required, pricing and reimbursement approvals), registration, license or authorization from a Regulatory Authority in a country or other jurisdiction that is necessary to market and sell such Product in such country or jurisdiction.

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Discover, Discovery means the first day on which a Breach becomes known to Contractor, or, by exercising reasonable diligence would have been known to Contractor.

  • Cancer means the presence of one or more malignant tumours including Hodgkin’s disease, leukaemia and other malignant bone marrow disorders, and characterised by the uncontrolled growth and spread of malignant cells and the invasion and destruction of normal tissue, but does not include the following:

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.